Article PDF
Avoid common mistakes on your manuscript.
References
Krishna D, Vyden J, Forrester J et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after cute myocardial infarction. N Engl J Med 1973; 288:1087–90.
Ross J, Braunswald E. Studies on Starling’s law of the heart. IX. The effects of impeding venous return on performance of the normal and failing human left ventricle. Circulation 1964; 30:719–27.
Maroko P, Kjekshus J, Sobel B et al. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971; 43:67–82.
Chatterjee K, Parmley W, Ganz W et al. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 1973; 48:1183–93.
Gray R, Chatterjee K, Vyden J et al. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J 1975; 90:346–52.
Miller R, Vismara L, Williams D et al. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Circ Res 1976; 39:127–33.
Arens J,Benbow B,chsner J et al. Morphine anesthesia for aortocoronary bypass procedures. Anesth Analg 1972; 51:901–7.
Tobias MA. Comparison of nitroprusside and nitroglycerin for controlling hypertension during coronary artery surgery. Br J Anaesth 1981 ; 53:891–6.
Kaplan J, Jones EL. Vasodilator therapy during coronary artery surgery. J Thorac Cardiovasc Surg 1979; 77:301–9.
Chiariello M, Gold HK, Leinbach RC et al. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 1976; 54:766–73.
Franciosa J, Guiha N, Limas C et al. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1972; 1:650–4.
Guiha N, Cohn J, Mikulic E et al. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 1974; 291:587–92.
Stinson E, Holloway E, Derby G et al. Control of myocardial performance early after open-heart opera tions by vasodilator treatment. J Thorac Cardiovasc Surg 1977; 73:523–30.
Cohn J. Blood pressure and cardiac performance. Am J Med 1973; 55:351–61.
Miller R, Vismara L, Zelis R et al. The clinical use of sodium nitroprusside in chronic ischemic heart disease. Circulation 1975; 51:328–36.
Kramer RS, Mason DT, Braunwald E. Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion. Circulation 1968; 38:629–34.
Mikulic E, Cohn J, Franciosa J. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Circulation 1977; 56:528–33.
Cohn J, Franciosa J. Selection of vasodilator, inotropic or combined therapy for the management of heart failure. Am J Med 1978; 65:181–8.
Chatterjee K, Parmley W, Swan JHC et al. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973; 48:684–90.
Goodman D, Rossen R, Holloway E et al. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation 1974; 50:1025–32.
Welch G, Braunwald E, Sarnoff S. Hemodynamic effects of quantitatively varied experimental aortic regurgitation. Circ Res 1975; 5:546–51.
Stone JG, Faltas A, Hoar P. Sodium nitroprusside therapy for cardiac failure in anesthetized patients with valvular insufficiency. Anesthesiology 1978; 49:414–8.
Bolen J, Alderman E. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 1976; 53:879–83.
Pepine C, Nichols W, Curry RC et al. Reversal of premature mitral valve closure by nitroprusside infusion in severe aortic insufficiency: beat-to-beat pressure-flow and echocardiographic relationships. (Abstract) Am J Cardiol 1976; 37:161.
Stone JG, Hoar P, Faltas A et al. Comparison of intraoperative nitroprusside unloading in mitral valve and aortic regurgitation. J Thorac Cardiovasc Surg 1979; 78:103–9.
Dalal FY, Bennett EJ, Salem MR et al. Anaesthesia for coarctation. Anaesthesia 1974; 29:704–9.
Noback C, Tinker J. Hypothermia after cardiopulmonary bypass. Anesthesiology 1980; 53:277–80.
Noback C, Marsh M, Tinker J. Prevention of post-cardiac surgical hypothermia. Anesthesiology 1980; 53:S182.
Colin JM, Burke LP. Nitroprusside. Ann Int Med 1979; 91:752–7.
Glass DD. Sodium nitroprusside. ASA Refresher Courses in Anesthesiology.Hershey SG (Ed.). 1977, 87–98. American Society of Anesthesiologists.
Petrovich L, Smith G, Quinones M et al. Hemodynamic effects of nitroglycerin vs. pure preload reduction masked arteriolar dilatory effect. Circulation 1978; 58:11–223.
Kaplan J (Ed.). Cardiac Anesthesia. 1979. Grune & Stratton, New York. 51–2.
Miller RR, Vismara CV, Williams DO et al. Mechanisms of ventricular unloading in heart failure. Circulation 1975; 52:II-76.
Gold H, Leinbach R, Sanders C. Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation 1972; 46:839–45.
Greenberg H, Dwyer E, James AG et al. Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. Am J Cardiol 1975; 36:426–33.
Mason D, Zelis R, Amsterdam E. Actions of the nitrates on the peripheral circulation and myocardial oxygen consumption. Chest 1971; 9:296–305.
Kaplan J, Dunbar R, Jones E. Nitroglycerin infusion during coronary artery surgery. Anesthesiology 1976; 45:14–21.
Brown BG, Bolson E, Petersen R et al. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Cirulation 1981; 64:1089–97.
Mann T, Cohn P, Holman L et al. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Circulation 1978; 57:732–8.
Goldstein R, Stinson E, Scherer J et al. Intraoperative coronary collateral function in patients with coronary occlusive disease. Circulation 1974; 49:298–308.
Epstein S, Kent KM, Goldstein R et al. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction. N Engl J Med 1975; 292:29–35.
Hirshfeld JW, Borer JS, Goldstein RE et al. Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion. Circulation 1974; 49:291–7.
Epstein S, Borer J, Kent KM et al. Protection of ischemic myocardium by nitroglycerin: experimental and clinical results. Circulation 53: Suppl 1976; 1–192-8.
Cohn PF, Maddox DE, Holman BL et al. Effects of sublingual nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 1977; 39:672.
Hill NS, Antman EM, Green LH et al. Intravenous nitroglycerin. Chest 1981; 79:69–75.
Armstrong PW, Walker DC, Burton JR et al. Vasodilator therapy in acute myocardial infarction. Circulation 1975; 52:1118–22.
Strauer BE, Scherpe A. Ventricular function and coronary hemodynamics after intravenous nitroglycerin in coronary arteries. Am Heart J 1978; 95:210–8.
Becker LC, FortuineNJ, Pitt B. Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res 1971; 28:263–9.
Rachley C, Hood W. Quantitative angiographic evaluation and pathophysiologic mechanisms in valvular heart disease. Prog Cardiovasc Dis 1973; 15:427–47.
Chatterjee K, Parmley W. The role of vasodilator therapy in heart failure. Prog Cardiovasc 1977; 19:301–25.
Kovick RB,Tillisch JH, Berens SC et al. Vasodilator therapy for chronic left ventricular failure. Circulation 1976; 53:322–8.
Ludbrook PA, Bryne JD, Kumik PB et al. Influence of reduction of preload and afterload by nitroglycerin on left ventricular diatolic pressure-volume relations and relaxation in man. Circulation 1977; 56:937–43.
Gold HK, Leinbach RC, Sanders CA. Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation 1972; 46:839–45.
Gibson GR, Hunter JB, Raabe DS et al. Methemoglobinemia produced by high dose intravenous nitroglycerin. Ann Int Med 1982; 96:615–16.
Zunick AM, Wagner NH, Starr NJ. Intravenous nitroglycerin, methemoglobinemia and respiratory distress in a postoperative cardiac surgical patient. Anesthesiology 1984; 61:464–6.
Nyesen-Karelse M, Dione RA, Jambroes G. Nifedipine in cardiac operations. J Thorac Cardiovasc Surg 1982; 84:145.
Midler JF, Gunther SJ. Nifedipine therapy for Prinzmetal’s Angina. Circulation 1978; 57: 137-9. 58 Goldberg S, Reichek N, Wilson J et al. Nifedipine in the treatment of Prinzmetal’s (variant) angina. Am J Cardiol 1979; 44:804–10.
Endo M, Kanada I, Hosoda S et al. Prinzmetal’s variant form of angina pectoris. Circulation 1975; 52:33–7.
Freedman B, Dunn RF, Richmond DR et al. Coronary artery spasm-treatment with verapamil. Circulation 1979; 60:II-249.
Sandier G, Clayton GA, Thornicroft SG. Clinical evaluation of verapamil in angina pectoris. Br Med J 1968; 3:244–7.
Aoki K, Kondo S, Mochizuki A et al. Antihypertensive effect of cardiovascular Ca+2-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 1978; 96:218–26.
Singh BN, Collett JT, Chew CYC. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980; 22:243–255.
Waxman HL, Myerburg RJ, Apple R et al. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann Int Med 1981; 94:1–6.
Zelis R, Flaim SF. Calcium influx blockers and vascular smooth muscle: Do we really understand the mechanisms? Ann Int Med 1981; 94:124–6.
Pepine CJ, Conti CR. Calcium blockers in coronary heart disease. Mod Concept Cardiovasc Dis 1981; 50:61–6.
Henry PD. Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol 1980; 46:1047–58.
Gunther S, Green L, Muller JE et al. Inappropriate coronary artery vasoconstriction in patients with coronary artery disease: a role for nifedipine? Am J Cardiol 1979; 44:793–7.
Lewis BH, Muller JE, Rutherford J et al. Nifedipine for coronary artery spasm after revascularization. N Engl J Med 1982; 306:992–3.
Kopf GS, Riba A,Zito R. Intraoperative use of nifedipine for hemodynamic collapse due to coronary artery spasm following myocardial revascularization. Ann Thor Surg 1982; 34:457–60.
Skawan K, Graedel E, Hasse J et al. Coronary artery spasms after coronary artery bypass surgery. Anesthesiology 1984; 61:323–7.
Humphrey L, Blanck T. Intraoperative use of verapamil for nitroglycerin-refractory myocardial ischemia. Anesth Analg 1985; 64:68–71.
Fyke FE, Vliestra RE, Damielson GK, Beynen FMK. Verapamil for refractory ventricular fibrillation during cardiac operations in patients with cardiac operations in patients with cardiac hypertrophy. J Thorac Cardiovasc Surg 1983; 86:108–11.
Kapur PA, Norel E, Dajee H, Amochowski G. Verapamil treatment of intractable arrythmias after cardiopulmonary bypass. Anesth Analg 1984; 65:460–3.
Clusin WT, Bustow MN, Karaguenzian HS, Katzung BG, Schroeder JS. Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation? Am J Cardiol 1982; 49:606–12.
Livesley B, Catley PF, Cambell RC et al. Double blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J 1973; 17:375–8.
Moskowitz RM, Piccini PA, Nacarelli GV et al. Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. Am J Cardiol 1979; 44:811–6.
New Therapy of Ischemic Heart Disease, edited by Jatere AD, Lichtlen PR. Amsterdam, Excerpta Medica 1976 p. 14.
Dargie JH, Lynch PG, Winkler NM et al. Nifedipine and propranolol: a beneficial drug interaction. Am J Med 1981; 71:676–82.
Zimpfer M, Fitzal S, Tonczar L. Verapamil as a hypotensive agent during neuroleptanaesthesia. Br J Anaesth 1981; 53:885–9.
Giffin J, Cottrell JE, Hartung J et al. Intracranial pressure during nifedipine-induced hypotension. Anesth Analg 1983; 62:1078–80.
Rowland E, Evans T, Krikler D. Effect of nifedipine on atrioventricular conduction as compared with verapamil. Br Heart J 1979; 42:124–7.
Chen CY, Hecht HS, Collett JT, McAllister RG, Singh BN. Influence of seventy of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol 1981; 47:917–22.
Ludbrook PA, Tiefenbrunn AJ, Reed FR et al. Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation 1982; 65:489–98.
Brooks N, Cattell M, Pidgeon J et al. Unpredictable response to nifedipine in severe cardiac failure. Br Med J 1980; 281:1324.
Gillmer DJ, Kark P. Pulmonary oedema precipitated by nifedipine. Br Med J 1980; 280:1420–1.
Singh JB, Hood WB, Abelmann WH. Beta adrenergic mediated inotropic and chronotropic actions of phentolamine. Am J Cardiol 1970; 26:660.
Bagwell EE, Hilliard CC, Daniell HB et al. Studies on the inotropic mechanism of phentolamine. Am J Cardiol 1970; 25:83.
Magid PA, Sharma B. Phentolamine for vasodilator treatment of severe heart failure. Lancet 1971 ; 719:23.
Wang HH, Liu LM, Kate RL. A comparison of the cardiovascular effects of sodium nitroprusside and trimethaphan. Anesthesiology 1977; 46:40–8.
Sladen RN, Rosenthal MD. Specific afterload reduction with parenteral hydralazine following cardiac surgery. J Thoracic Cardiovasc Surg 1979; 78:125–202.
Stevens WC, Cromwell TH, Halsey MJ et al. The cardiovascular effects of a new inhalation anesthetic, forane, in human volunteers at constant arterial carbon dixodie tension. Anesthesiology 1970; 35:8–16.
Calverley RK, Smith NT, Prys-Roberts C et al. Cardiovascular effects of enflurane anesthesia during controlled ventilation in man. Anesth Analg 1976; 57:619–28.
Deutsch S, Linde HW, Dripps RD et al. Circulatory and respiratory actions of halothane in normal man. Anesthesiology 1962; 23:631–8.
Eger EL,Smith NT,Stoelting RK et al. Cardiovascular effects of halothane in man. Anesthesiology 1970; 32:396–408.
Clark RE, Christlieb IY, Henry PD et al. Nifedipine: a myocardial protective agent. Am J Cardiol 1979; 44:825–31.
Reiz S, Balfors E, Gustavsson B et al. Effects of halothane on coronary hemodynamics and myocardial metabolism in patients with ischemic heart disease and heart failure. Acta Anaesthesiol Scand 1982; 26:133.
Rydvall A, Haggmark S, Nyhman H, Reiz S. Effects of enflurane on coronary hemodynamics in patients with ischemic heart disease. Acta Anaesthesiol Scand 1984; 28:690–5.
Gelman S, Fowler K, Smith L. Regional blood flow during isoflurane and halothane anesthesia. Anesth Analg 1984; 63:557–65.
Reiz S, Balfors E, Sorenson M et al. Isoflurane-a powerful vasodilator in patients with coronary artery disease. Anesthesiology 1983; 59:91–7.
Reiz S, Ostman M. Regional coronary hemodynamics during isoflurane-nitrous oxide anesthesia in patients with ischemic heart disease. Anesth Analg 1985; 64:570–6.
Buffington CW,Romson JL,Duttlinger NL. Does isoflurane cause coronary steal? Anesthesiology 1985; 63:A9.
Morrow DH, Morrow AG. The effects of halothane on myocardial contractile force and vascular resistance. Anesthesiology 1961; 22:537–41.
Brown BR, Cront JR. A comparative study of the effects of five general anesthetics on myocardial contractility. Anesthesiology 1971; 34:236–45.
Sonntag H, Donath M, Hillebrand W et al. Left ventricular function in conscious man and during halothane anesthesia. Anesthesiology 1978; 48:320–24.
Kemmotsu O, Hashimoto Y, Shimosato S. Inotropic effects of isoflurane on mechanism of contraction in isolated cat papillary muscles from normal and failing hearts. Anesthesiology 1973; 39:470–7.
Stinson EB, Holloway EL, Derby G et al. Comparative hemodynamic responses to chloropromazine, nitroprusside, nitroglycerin and trimethaphan immediately after open heart surgery. Circulation 1974; 52:126–33.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fyman, P.N., Cottrell, J.E., Kushins, L. et al. Vasodilator therapy in the perioperative period. Can Anaesth Soc J 33, 629–643 (1986). https://doi.org/10.1007/BF03014269
Issue Date:
DOI: https://doi.org/10.1007/BF03014269